Ajanta Pharma Ltd
NSE:AJANTPHARM

Watchlist Manager
Ajanta Pharma Ltd Logo
Ajanta Pharma Ltd
NSE:AJANTPHARM
Watchlist
Price: 2 859.8501 INR 1.24%
Market Cap: 357.2B INR
Have any thoughts about
Ajanta Pharma Ltd?
Write Note

Ajanta Pharma Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ajanta Pharma Ltd
Cash Equivalents Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Ajanta Pharma Ltd
NSE:AJANTPHARM
Cash Equivalents
â‚ą10.4m
CAGR 3-Years
-43%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash Equivalents
â‚ą7.1B
CAGR 3-Years
-22%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash Equivalents
â‚ą9.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
16%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash Equivalents
â‚ą90.2B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
4%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash Equivalents
â‚ą11.5B
CAGR 3-Years
49%
CAGR 5-Years
14%
CAGR 10-Years
7%
M
Mankind Pharma Ltd
NSE:MANKIND
Cash Equivalents
â‚ą1.2B
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ajanta Pharma Ltd's Cash Equivalents?
Cash Equivalents
10.4m INR

Based on the financial report for Sep 30, 2024, Ajanta Pharma Ltd's Cash Equivalents amounts to 10.4m INR.

What is Ajanta Pharma Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
-24%

Over the last year, the Cash Equivalents growth was 9%. The average annual Cash Equivalents growth rates for Ajanta Pharma Ltd have been -43% over the past three years , -24% over the past five years .

Back to Top